Is Your Biotech ETF Keeping Up With 3 New Standouts?
It’s old hat that biotech ETFs are beating the stock market. But three are new launches flying under the radar of many investors.
BioShares Biotechnology Products
(NASDAQ:
) holds stocks such as
Celgene
(NASDAQ:
) and
Anacor Pharmaceuticals
(NASDAQ:
) that have shone of late. Two others focus on businesses in the clinical trial stage.
View original –
Is Your Biotech ETF Keeping Up With 3 New Standouts?
See which stocks are being affected by Social Media
